In people with Parkinson’s disease, sleep disturbances and excessive daytime sleepiness (EDS) were associated with the impairment of the…
Articles by Steve Bryson, PhD
Noninvasive low-intensity focused ultrasound (LIFU) temporarily opened the blood-brain barrier to allow molecules to enter the brains of Parkinson’s…
The Michael J. Fox Foundation (MJFF) has awarded a $150,000 grant to a biopharmaceutical company seeking to develop a…
Greater proportions of immune regulatory B-cells were associated with better motor performance in people with early Parkinson’s disease, a…
Parkinson’s disease patients carrying severe variants in the GBA gene, a known genetic risk factor, experience faster motor and…
People with Parkinson’s disease have higher than normal levels of a nerve cell-damaging red/yellow pigment called pheomelanin in their…
Researchers at Michigan Technological University are developing a “smart” deep brain stimulation (DBS) system to treat Parkinson’s disease…
Inflammatory biomarkers in the cerebrospinal fluid (CSF) of Parkinson’s disease patients with and without mutations in the GBA gene are…
Symbyx Neuro, Symbyx Biome’s red/infrared light therapy helmet, improves motor function in Parkinson’s disease, according to data from…
The U.S. Department of Defense has awarded $400,000 to an Augusta University (AU) neuroscientist to research a possible brain-gut connection…